Do patient-related blood donors represent a threat to the safety of the blood supply?

Haematologica

Volumn 87, Issue 4, 2002, Pages 427-433

  Pereira, Arturo ^a   Sanz, Cristina ^a   Tàssies, Dolors ^a   Ramírez, Begoña ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Blood donors; Tranfusion transmitted infections

Indexed keywords

ADULT; ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; COMMUNITY; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG USE; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION; LIVER DISEASE; LIVING DONOR; MALE; PREVALENCE; RISK FACTOR; SAFETY; SOCIAL ASPECT; VIRUS DETECTION; VIRUS TRANSMISSION;

ADULT; ANTIGENS, VIRAL; BLOOD BANKS; BLOOD DONORS; CONSUMER PRODUCT SAFETY; FEMALE; HUMANS; MALE; NUCLEAR FAMILY; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS; VIREMIA;

EID: 0036219001     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Epidemiology of blood transfusion and forecast of the demand of blood
2. NBDRC addresses blood supply issues and predicts shortages
3. Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study
4. Verification of the drug history by potential blood donors: Results of drug screening that combines hair and urine analysis
5. The risk of transfusion-transmitted infection: Direct estimation and mathematical modeling
6. Test-seeking as motivation in volunteer blood donors
7. Risk behavior among blood donors who give blood in order to be tested for the human immunodeficiency virus
8. Role of silent hepatitis B virus in chronic hepatitis B surface antigen-negative liver disease
9. Potential increased risk of virus transmission due to exclusion of older donors because of concern about Creutzfeldt-Jakob disease
10. Directed donations for pediatric patients
11. Viral marker rates among unpaid blood donors in Europe decreased from 1990 to 1996
12. Increasing diversity of HIV-1M serotypes in French blood donors over a 10-year period (1985-1995)
13. Surveillance of HIV-1 genetic subtypes and diversity in the US blood supply
14. Prevalence and epidemiological characteristics of hepatitis C in Scottish blood donors
15. Epidemiology, serological markers, and hepatic diseases of anti-HCV ELISA-2-positive blood donors
16. Hepatitis C virus: Routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors
17. Risk factors for acquisition of hepatitis C virus infection in blood donors: Results of a case-control study
18. Characteristics of hepatitis C-positive blood donors in Victoria Australia
19. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)
20. The incidence and risk factors of community-acquired hepatitis C in a cohort of Italian blood donors
21. Transmission of hepatitis C virus: A study of the main risk factors in a Sicilian population of volunteer blood donors
22. Hepatitis C in a French population-based survey, 1994: Seroprevalence, frequency of viremia, genotype distribution and risk factors
23. Distribution of hepatitis C virus genotypes among intravenous drug users. A ten-year study in Palermo, Sicily
24. Hepatitis C virus serotypes and sources of infection in patients with HCV-related chronic liver disease from one geographical area in southeast Italy
25. Genotyping of hepatitis C virus isolates from Basque Country, Spain
26. Variants of hepatitis C virus in different risk groups. Comparative study of a method for genotyping and another for serotyping
27. Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin
28. Characteristics of hepatitis C virus among intravenous drug users in Iceland
29. Distribution of hepatitis C virus in German patients with chronic hepatitis C: Correlation with clinical and virological parameters
30. Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s
31. Influence of viraemia and genotype upon serological reactivity in screening assays for antibody to hepatitis C virus
32. Low levels of hepatitis C virus RNA in serum, plasma, and periphera blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion